Immunoglobulin E vaccine - Pfizer

Drug Profile

Immunoglobulin E vaccine - Pfizer

Alternative Names: Anti-IgE vaccine - Pfizer; Anti-immunoglobulin-E vaccine - Pfizer; IGE-1; IGE-2; PF-06444752; PF-06444753; PF-6444752; PF-6444753

Latest Information Update: 22 Mar 2016

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Pfizer
  • Class Allergy immunotherapies; Vaccines; Virus-like particle vaccines
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Asthma; Perennial allergic rhinitis

Most Recent Events

  • 22 Mar 2016 Safety and immunogenicity data from a phase I trial in Asthma was presented at the 2016 Annual Meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI-2016)
  • 28 Oct 2015 Discontinued - Phase-I for Asthma (IM)
  • 28 Oct 2015 Discontinued - Phase-I for Perennial allergic rhinitis in Canada (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top